menu
    • menu
    [{"orgOrder":0,"company":"CeraVe","sponsor":"CeraVe","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Cetaphil","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase IV","graph3":"CeraVe","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Cream","sponsorNew":"CeraVe \/ CeraVe","highestDevelopmentStatusID":"11","companyTruncated":"CeraVe \/ CeraVe"}]

    Find Clinical Drug Pipeline Developments & Deals by CeraVe

    Menu

    CeraVe

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            CeraVe

                            Canada arrow
                            Organic Process R&D
                            Not Confirmed

                            CeraVe

                            Canada arrow
                            Organic Process R&D
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cetaphil

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase IV

                            Recipient : University of Miami

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            CeraVe Diabetes Mellitus

                            Details : Cetaphil is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Complications.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            January 26, 2021

                            Lead Product(s) : Cetaphil

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase IV

                            Recipient : University of Miami

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth